Medication Profile · Updated November 2026

Ozempic (Semaglutide): Cost, Dosing, and Where to Get It in 2026

Ozempic costs $349 per month for the 0.25 mg, 0.5 mg, and 1 mg pens when you buy directly from Novo Nordisk's NovoCare Pharmacy without insurance, and $499 for the 2 mg pen. New self-pay patients pay $199 per month for the first two fills of the 0.25 mg or 0.5 mg pen (through December 31, 2026), and the new Ozempic tablets start at $149. I am personally on Mounjaro (tirzepatide), but half the people who message me about GLP-1s are asking about Ozempic. Direct-from-Novo pricing has changed the cash-pay picture. Here is where things stand on November 4, 2026.

Quick Facts

How Ozempic Works

Ozempic is a GLP-1 receptor agonist. It mimics a hormone your body naturally produces called glucagon-like peptide-1 (GLP-1). When you inject semaglutide, it activates GLP-1 receptors in the brain and gut, producing three main effects:

1. Appetite reduction. GLP-1 signals satiety to the hypothalamus in your brain. You feel full sooner and think about food less. This is the primary driver of weight loss.
2. Slower gastric emptying. Food stays in your stomach longer, which keeps you feeling satisfied between meals and reduces blood sugar spikes after eating.
3. Improved insulin response. Your pancreas releases insulin more effectively in response to food. This is why Ozempic was originally approved for type 2 diabetes.

The weight loss from Ozempic is dose-dependent. Higher doses produce more appetite suppression and more weight loss, which is why the dosing schedule starts low and gradually increases over several months.

For a deeper breakdown of the single-action GLP-1 mechanism vs. dual-action drugs like Mounjaro, see our Mounjaro vs Ozempic comparison.

Dosing Schedule

Ozempic uses a step-up dosing protocol to minimize side effects. Per the Ozempic label, you start at 0.25 mg for four weeks, then move to 0.5 mg. Going higher is not automatic. Your prescriber increases the dose only if you need more blood sugar control, and only after at least four weeks at the current dose.

Many patients stay at 0.5 mg or 1 mg. Your prescriber should base any increase on your blood sugar response and how you tolerate the drug. Do not raise the dose on your own. Ozempic is not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, and the label says to stop it at least 2 months before a planned pregnancy.

One important note: Ozempic’s maximum dose (2 mg) is lower than Wegovy’s. Wegovy was specifically designed for weight management, includes the 1.7 mg and 2.4 mg maintenance levels that Ozempic does not have, and offers a 7.2 mg Wegovy HD dose. If weight loss is your primary goal and you have plateaued at 2 mg Ozempic, your doctor may consider switching you to Wegovy for the higher dosing options.

Weight Loss Results

Ozempic was originally approved for type 2 diabetes, not weight management. But the clinical trial data shows meaningful weight loss across multiple studies. The diabetes and weight-loss doses are not the same, which I break down in GLP-1 for type 2 diabetes vs weight loss.

STEP 8 Trial (semaglutide 2.4 mg vs. daily liraglutide):

• Participants on semaglutide 2.4 mg (the Wegovy dose) lost approximately 15.8% of body weight at 68 weeks
• Participants on liraglutide 3 mg (Saxenda) lost approximately 6.4% over the same period

Correction (August 2026): an earlier version of this page described STEP 8 as a comparison of semaglutide 2.4 mg against 1 mg. STEP 8 compared semaglutide against liraglutide. The 1 mg figures below come from the SUSTAIN program.

SUSTAIN Trials (Ozempic-specific):

• SUSTAIN 1: 3.7 kg (8.2 lbs) weight loss at 30 weeks with 0.5 mg and 4.5 kg with 1 mg
• SUSTAIN 2: 4.3 to 6.1 kg (9.5 to 13.4 lbs) weight loss at 56 weeks

What does this mean in real terms? The headline semaglutide numbers come from the 2.4 mg Wegovy dose. On Ozempic’s standard 1 mg dose, the SUSTAIN 2 data points to roughly 13 lbs over about a year in people with type 2 diabetes. At Wegovy’s 2.4 mg dose, the STEP 1 average of 14.9% works out to about 33 lbs for a 220 lb person at 68 weeks.

These are averages. Individual results vary significantly based on diet, exercise, starting weight, and how your body responds to the medication. From my own experience tracking DEXA scans while on a GLP-1, the composition of that weight loss matters as much as the number on the scale. If you are not doing resistance training, a meaningful portion of the weight you lose will be muscle. Our fat loss vs weight loss guide breaks this down in detail.

For context, in the head-to-head SURMOUNT-5 trial, tirzepatide (Mounjaro’s molecule) produced 20.2% weight loss vs 13.7% for semaglutide 2.4 mg. See the full comparison.

What Ozempic Costs in 2026

Here is what you are looking at as of November 4, 2026.

Brand-Name Ozempic

Novo Nordisk has announced it will cut Ozempic’s list price to $675 a month on January 1, 2027. Most cash payers already pay less than that. Novo Nordisk sells Ozempic directly to cash-pay patients through NovoCare Pharmacy at $349 per month for the 0.25 mg, 0.5 mg, and 1 mg pens and $499 per month for the 2 mg pen, per its price guide (checked Nov 4, 2026). New self-pay patients get an introductory rate of $199 per month for the first two fills of the 0.25 mg or 0.5 mg pen, an offer Novo lists as running through December 31, 2026. For more cash-pay options, see our 2026 GLP-1 Cash-Pay Pricing Index.

Novo Nordisk Savings Card: If you have commercial insurance (not Medicare or Medicaid) and your plan covers Ozempic, the savings offer covers up to $100 per month. That can bring your copay down to as little as $25 per month. Check NovoCare.com for current eligibility.

With insurance: Most commercial insurance plans cover Ozempic for type 2 diabetes, and your copay depends on your plan’s formulary tier. Coverage for weight loss (off-label use) is less consistent. See our insurance coverage guide for strategies to get approved. If you are on Medicare, semaglutide (Ozempic, Rybelsus and Wegovy) has a Medicare negotiated price taking effect January 1, 2027. Your Part D plan still sets the actual copay and can require prior authorization.

The Ozempic Pill (New in 2026)

Ozempic tablets come in 1.5 mg, 4 mg, and 9 mg doses and share a label with Rybelsus. The label says the two tablets are not interchangeable mg for mg. Self-pay pricing through NovoCare Pharmacy is $149 per month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg. Like the injection, the tablets are approved for type 2 diabetes. You take them each morning on an empty stomach with up to 4 ounces of water, then wait at least 30 minutes before eating, drinking or taking other oral medicines. The tradeoff is a daily pill instead of a weekly injection, which some people prefer and others find harder to stay consistent with.

What Happened to Compounded Semaglutide

For about two years, compounded semaglutide at $149 to $299 per month was the budget path to this medication. That era is mostly over. The FDA declared the semaglutide shortage resolved on February 21, 2025, and the grace periods for compounders ended April 22, 2025 (503A) and May 22, 2025 (503B). FDA says semaglutide is on neither the shortage list nor the 503B bulks list, so outsourcing facilities can no longer make copies.

A narrow lane remains. Some providers still prescribe compounded semaglutide through 503A pharmacies. The programs we checked listed about $125 to $297 per month on November 4, 2026 (see our compounded semaglutide page). FDA does not review compounded drugs for safety, effectiveness or quality, and it has received reports of hospitalizations linked to dosing errors with compounded semaglutide. For a detailed breakdown, read our compounded vs brand-name guide. With Novo’s direct price now at $349, the savings gap that drove the compounded market has mostly closed.

Cost Comparison Summary

For a full pricing breakdown across all providers and medication types, see our cheapest GLP-1 online guide.

Where to Get Ozempic (or Compounded Semaglutide) Online

These are telehealth providers in our directory that offer semaglutide. The mix changed in 2026: most large platforms now prescribe brand-name medication at Novo’s direct prices, while a few still offer compounded semaglutide through 503A pharmacies. You can also skip telehealth entirely and buy directly from Novo through NovoCare Pharmacy with a prescription from your own doctor.

For a full comparison of every GLP-1 telehealth provider we track (with pricing, insurance acceptance, and coverage maps), visit our provider directory.

Common Side Effects

GLP-1 medications share a similar side effect profile. Most side effects are gastrointestinal and tend to be worst during the first few weeks of each dose increase. They typically improve as your body adjusts.

Most common (5% or more of patients in trials, per the Ozempic label):

• Nausea (15.8% on 0.5 mg and 20.3% on 1 mg, vs 6.1% on placebo)
• Diarrhea
• Vomiting
• Constipation
• Abdominal pain

Less common but reported:

• Headache
• Fatigue
• Dizziness
• Injection site reactions (redness, swelling)
• Decreased appetite (this is technically the mechanism working, not a side effect)

Serious but rare:

• Pancreatitis (inflammation of the pancreas). Seek medical attention for severe, persistent abdominal pain.
• Gallbladder problems, including gallstones
• Changes in vision in patients with type 2 diabetes (diabetic retinopathy)
• Kidney problems, usually related to dehydration from nausea/vomiting

Boxed warning: Semaglutide carries a boxed warning about thyroid C-cell tumors observed in rodent studies. This risk has not been confirmed in humans, but Ozempic is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

For a month-by-month breakdown of what to expect (and what actually helped me manage GI side effects on Mounjaro), read our GLP-1 side effects guide.

Ozempic vs. Related Medications

Ozempic exists in a family of GLP-1 drugs. Here is how it compares.

Ozempic vs. Wegovy: Same active ingredient (semaglutide), different approved uses. Wegovy is FDA-approved for weight management and now runs up to a 7.2 mg Wegovy HD dose. Ozempic maxes out at 2 mg and is approved for diabetes. If weight loss is your goal, Wegovy is the version designed for you. Full Wegovy profile.

Ozempic vs. Mounjaro: Mounjaro (tirzepatide) works on two receptors (GIP and GLP-1) compared to Ozempic’s one (GLP-1 only). In the head-to-head SURMOUNT-5 trial, tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide. Full comparison. If you are thinking about moving over, read what switching from Ozempic to Mounjaro involves.

Ozempic vs. Compounded Semaglutide: Ozempic is manufactured by Novo Nordisk and FDA-approved. Compounded semaglutide is not an FDA-approved generic, and FDA does not review compounded products for safety, effectiveness, quality, or bioequivalence before marketing. Compounding may occur under the 503A or 503B frameworks when applicable requirements are met. Compounded vs brand-name guide.

Frequently Asked Questions

What we checked

This AI-assisted public-source desk check reviewed the Ozempic injection and tablet prescribing information, the FDA approval record, FDA compounding policy and safety pages, the SUSTAIN 1, SUSTAIN 2, STEP 1, STEP 8 and SURMOUNT-5 trial publications, NovoCare’s Ozempic price guide, CMS’s negotiated price page, Novo Nordisk’s list price announcement, and the MEDVi and Ro pricing pages on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.

Related Resources

• Mounjaro vs Ozempic vs Wegovy vs Zepbound (2026)
• Cheapest Way to Get GLP-1 Medications Online
• GLP-1 Side Effects: Month by Month Guide
• Compounded vs Brand-Name GLP-1: What You Need to Know
• How to Get GLP-1 Medications Without Insurance
• Exercise and Muscle Preservation on GLP-1s